Revenue segments as reported by the company.

Clearing and transaction fees

Market data and information services

Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Compensation and benefits  

Technology

Professional fees and outside services

Amortization of purchased intangibles

Depreciation and amortization

Licensing and other fee agreements

Other expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CME Group

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CME Group achieves record-breaking 2022 performance amidst market challenges

CME Group's 2022 performance was exceptional, marked by record volumes, revenue growth, and successful transitions. The company's focus on innovation, strategic positioning in energy and cryptocurrency markets, and pricing adjustments have driven positive outcomes. Challenges in margins and market uncertainties require careful navigation.

CME Group posts record Q1 earnings, eyes growth in SOFR

CME Group delivered a strong performance in Q1 2023, achieving record revenue and profitability driven by growth in interest rate and options trading.
The company's strategic focus on risk management, shareholder value creation, and market competitiveness positions it well for future growth and revenue generation.
While facing challenges in a competitive market environment, CME Group has opportunities to capitalize on the demand for SOFR products and options trading.
Optimism surrounding the company's future growth potential, coupled with effective expense management and revenue diversification, underpin its resilience and strategic outlook.

CME Group excels in Q2 with record revenue and strategic focus

CME Group's Q2 earnings call showcased strong financial performance, driven by growth across asset classes and a focus on customer-centric strategies. The company's emphasis on innovation, regulatory compliance, and market leadership positions it well for future growth.

CME Group reports strong Q3 earnings, eyes growth amid challenges

CME Group's Q3 2023 earnings call highlighted robust financial performance, operational efficiency, and strategic positioning. Despite facing regulatory challenges and cost management concerns, the company remains confident in its offerings and growth prospects. Opportunities for expansion through innovation and capitalizing on market trends were key discussion points.

CME Group achieves record 2023 results amidst global uncertainties

CME Group's record-breaking performance in 2023 underscores its market leadership and financial strength, with revenue growth, margin expansion, and strong product demand driving positive results.
While facing challenges from global uncertainties and market dynamics, the company's strategic focus on innovation, risk management, and efficiency positions it well to capitalize on opportunities in evolving markets.
By introducing new products, expanding partnerships, and navigating changing market conditions adeptly, CME Group demonstrates resilience and adaptability, paving the way for continued growth and success in the financial industry.
Overall, CME Group's strategic initiatives, financial performance, and market positioning reflect a company poised for sustained success, leveraging opportunities and strengths to overcome challenges and drive future growth.

CME Group achieves record earnings in Q1 2024, eyes growth

CME Group delivered a strong performance in Q1 2024, setting records in revenue and earnings.
The company faces challenges in managing expenses amid growth initiatives and competitive dynamics.
However, CME's strengths in market leadership, network infrastructure, and regulatory alignment position it well for future opportunities.
By capitalizing on data services and revenue growth avenues, CME can continue its upward trajectory in the market.

CME Group achieves record Q3 performance amidst regulatory challenges

CME Group's Q3 performance was exceptional, marked by record volumes and financial metrics. Despite challenges in regulatory compliance and competition, the company is well-positioned for growth through strategic opportunities in interest rate products and retail expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CME Group stands out as a resilient financial dividend stock, capitalizing on market volatility and avoiding credit risks faced by many regional banks. CME Group's extensive range of derivatives, diverse exchanges, and role as a primary price discovery provider makes it a standout asset-light business with high barriers to entry. With a robust dividend history, consistent growth, and a favorable valuation, CME Group presents a compelling opportunity for long-term investors seeking strong dividend yields in a volatile market.

CME Group: My Favorite Financial Dividend Stock

Meta, CME Lead Top Stocks Breaking Out With This Bullish Trait

FactSet Research Systems

Financial markets rely on a multitude of companies to grow and evolve. CME Group is the top derivatives exchange operator and benefits from volatile markets.

2 Top Financial Services Stocks to Buy in October

Coinbase

NVIDIA

Block

Visa

Five stocks to watch in a range-bound cryptocurrency markets are: NVDA, V, SQ, COIN, CME.

5 Crypto Stocks to Watch in a Rangebound Market

Highest-ever Q3 volume for interest rate and agricultural products Record Equity Index options in September and Q3 CHICAGO , Oct. 3, 2023 /PRNewswire/ --  CME Group , the world's leading derivatives marketplace, today reported its September and Q3 2023 market statistics, reaching an average daily volume (ADV) of 22.7 million contracts in September, representing the company's second-highest September ADV on record. Q3 ADV was 22.3 million contracts, the second-highest Q3 volume ever.

CME Group Reports Second-Highest September and Q3 ADV on Record

BellRing Brands Inc

Exelixis

Low-beta stocks allow investors to sleep well at night as the latest developments on interest rate hikes and their effects on the market cause anxiety. Despite things being slightly better than in previous years, central banks are still open to increasing interest rates, and oil prices are still rising.

Steady Eddies: 3 Low Beta Stocks for Long-Haul Gains

CME Group's (CME) global presence, compelling product portfolio and focus on over-the-counter clearing services and effective capital deployment poise it well for growth.

CME Group (CME) Rises 19% YTD: Can It Retain the Bull Run?

CHICAGO , Sept. 27, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it will launch Micro Henry Hub futures and options on November 6, pending all relevant regulatory reviews.

CME Group to Launch Micro Henry Hub Futures and Options on November 6

The article discusses CME Group's performance year to date, with a focus on the current interest rate environment and volatile equity markets. The company beat both revenue and earnings estimates in Q2, and key performance indicators such as ADV and average RPC confirm continued strong performance. While interest rate and equity index-related products continue to be primarily responsible for the strong performance, investors shouldn't underestimate the potential of CME's market data and information segment.

CME Group: Still The Perfect Fit For An All-Weather Portfolio

CHICAGO , Sept. 18, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that Micro E-mini Nasdaq-100 futures surpassed 1 billion contracts traded on September 13.

Micro E-mini Nasdaq-100 Futures Surpass 1 Billion Contracts Traded

CHICAGO , Sept. 18, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it will launch Cobalt Hydroxide futures on October 23, pending all relevant regulatory reviews.

CME Group to Launch Cobalt Hydroxide Futures on October 23

CHICAGO , Sept. 13, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced registration is now open for the 20th annual CME Group University Trading Challenge, which will be held from Sunday, October 1 to Friday, October 27.

CME Group Opens Registration for its 20th Annual Global University Trading Challenge

CHICAGO , Sept. 12, 2023 /PRNewswire/ -- CME Group Inc. will announce earnings for the third quarter of 2023 before the markets open on Wednesday, October 25, 2023.

CME Group Inc. Announces Third-Quarter 2023 Earnings Release, Conference Call

CHICAGO and NEW YORK and LONDON and HONG KONG and SINGAPORE and SYDNEY , Sept. 12, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, and The Depository Trust & Clearing Corporation (DTCC), the premier post-trade market infrastructure for the global financial services industry, today announced their enhanced cross-margining arrangement has received Securities and Exchange Commission (SEC) and Commodity Futures Trading Commission (CFTC) approvals.

CME Group and DTCC Receive Regulatory Approval for Enhanced Treasury Cross-Margining Arrangement Launching January 2024

CHICAGO , Sept. 11, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it will launch options on Micro Gold futures on October 2, 2023, pending regulatory review.

CME Group to Launch Options on Micro Gold Futures as Retail Participation Jumps

CHICAGO , Sept. 7, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that trading in its suite of WTI weekly options, the company's fastest growing energy products, reached record average daily volume in August of 12,291 contracts.

CME Group Announces Record Volume Across Suite of Short-Term WTI Options

CHICAGO , Sept. 5, 2023 /PRNewswire/ -- CME Group , the world's leading derivatives marketplace, today announced that it will expand its benchmark interest rates offering with the launch of U.S. Treasury Bill (T-Bill) futures on October 2, pending regulatory review.

CME Group to Launch T-Bill Futures on October 2, as U.S. Treasury Futures Open Interest Hits Record 19.8 Million Contracts

Double-digit growth in Interest Rate, Energy, Agricultural, Metals and options products Highest-volume August for Equity Index futures and options and Agricultural options products CHICAGO , Sept. 5, 2023 /PRNewswire/ -- Amid ongoing geopolitical, economic and weather-related uncertainties, CME Group, the world's leading derivatives marketplace, today reported its August 2023 market statistics, including average daily volume (ADV) of 24.2 million contracts, an increase of 14% from 2022 and the second-highest ADV for the month of August on record.

CME Group Reports Second-Highest August ADV on Record

CME Group (CME) Rises 20.6% YTD: Time to Buy the Stock?

Here is how CME Group (CME) and Robinhood Markets, Inc. (HOOD) have performed compared to their sector so far this year.

Are Finance Stocks Lagging CME Group (CME) This Year?

CHICAGO , Aug. 31, 2023 /PRNewswire/ -- CME Group Foundation today announced an initial $2 million in funding to expand its grantmaking program to support young women and girls impacted by trauma and violence in Chicago. "We are pleased to make these initial grants that will bring high-quality mental health resources to young women and girls in Chicago's underserved communities," said Terry Duffy, CME Group Chairman & Chief Executive Officer and Vice Chairman of CME Group Foundation.

CME Group Foundation Launches $2 Million Grantmaking Initiative to Support Mental Health of Young Women and Girls in Chicago

CME Group's stock (NYSE: CME) has gained 21% YTD, as compared to the 15% rise in the S&P500 over the same period.

What To Expect From CME Group Stock?

CME (CME) reported earnings 30 days ago. What's next for the stock?

Why Is CME (CME) Up 0.7% Since Last Earnings Report?

CHICAGO and LONDON , Aug. 16, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, and CF Benchmarks, the leading provider of cryptocurrency benchmark indices, today announced plans to launch two new APAC-specific reference rates for bitcoin and ether on September 11 – the CME CF Bitcoin Reference Rate APAC (BRRAP) and CME CF Ether-Dollar Reference Rate APAC (ETHUSD_AP) – which will provide a once-a-day reference rate for the U.S. dollar price of the two digital assets, published at 4 p.m. Hong Kong/Singapore time.

CME Group and CF Benchmarks to Launch APAC Reference Rates for Bitcoin and Ether on September 11

Paul Houston Appointed to Lead Combined FX Products Group CHICAGO and LONDON , Aug. 16, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced a realignment of its FX futures, options, cash and over-the-counter (OTC) FX businesses into a single unit led by Paul Houston, who has overseen CME Group's futures and options business for seven years.  Under the new structure, Houston will serve as Global Head of FX Products and will be responsible for the company's FX derivatives markets as well as its EBS cash markets business, leveraging a combined team to further improve client service, increase efficiencies and enhance product development across the entire FX marketplace.

News for CME Group Stock (CME)